Responsive image
博碩士論文 etd-0615113-135504 詳細資訊
Title page for etd-0615113-135504
論文名稱
Title
吡類手性噁唑啉雙螯基配體銅催化不對稱亨利反應之研究
Asymmetric Henry Reaction Catalyzed by Copper Complexes of Pyrazole-containing Chiral Oxazoline Bidentate Ligands
系所名稱
Department
畢業學年期
Year, semester
語文別
Language
學位類別
Degree
頁數
Number of pages
144
研究生
Author
指導教授
Advisor
召集委員
Convenor
口試委員
Advisory Committee
口試日期
Date of Exam
2013-06-25
繳交日期
Date of Submission
2013-07-15
關鍵字
Keywords
手性噁唑啉-氮配體、吡類手性噁唑啉配體、不對稱銅金屬催化亨利反應、氮氮類型配體、二價銅催化反應
Asymmetric Henry Reaction, Henry reaction, Oxazoline, N, N-Bidentate Ligands, Pyrazole Chiral oxazoline
統計
Statistics
本論文已被瀏覽 5684 次,被下載 371
The thesis/dissertation has been browsed 5684 times, has been downloaded 371 times.
中文摘要
摘要
  多種新型的吡類手性噁唑啉雙螯基配體在此論文中設計出且簡單的成功合成出來,並且嘗試運用於二價銅催化不對稱亨利反應中。在二價銅催化的常溫不對稱亨利反應中,可以從不同路易士酸來源的條件,得到位向相反的化合物。實驗中,與Cu(OTf)2形成金屬錯合物催化的常溫不對稱亨利反應得到R位向的化合物 (Yield 97%, 37% ee), Cu(OAc)2形成的金屬錯合物則得到S位向的鄰硝基醇化合物 (Yield 82%, 17% ee)
Abstract
A series of new pyrazole-containing chiral oxazoline bidentate ligands have been designed, successfully synthesized, and applied to Asymmetric Henry Reaction. Pyrazole-containing chiral oxazoline bidentate ligand has been investigated in catalytic asymmetric Henry reaction of nitroaldol compound with different Lewis acids.The Cu(OTf)2 complex furnished R enantiomer (yield 97%, 37% ee), and Cu(OAc)2 complex afforded S enantiomer (yield 82%, 17% ee).
目次 Table of Contents
目錄
摘要 ............................................................................................................. i
英文摘要 .................................................................................................... ii
第一章 緒論 ............................................................................................... 1
1.1 手性分子 ........................................................................................... 2
1.2得到不對稱結構的方法 ................................................................... 4
1.2.1 Racemate resolution ................................................................. 4
1.2.2 Chiral pool ................................................................................ 6
1.2.3 Stereoselective synthesis .......................................................... 7
1.3 亨利反應 ........................................................................................ 10
1.4 金屬催化不對稱反應 .................................................................... 14
1.5 與金屬錯合的配體 ........................................................................ 15
1.6 金屬催化不對稱亨利反應 ............................................................ 16
1.7 其他多種金屬催化不對稱亨利反應 ............................................ 17
1.7.1 鋅金屬催化 .............................................................................. 17
1.7.2 鎘金屬催化 .............................................................................. 18
1.7.3 鈷金屬催化 .............................................................................. 18
1.8噁唑啉 (Oxazoline)系列配體 ........................................................ 20
1.9 希夫鹼 (Schiff base)系列配體 ...................................................... 22
1.10 其他氮氮配體 .............................................................................. 25
1.11. Hybrid ligands .............................................................................. 29
1.12 噁唑啉 (oxazoline) ...................................................................... 31
1.12.1 噁唑啉如何與金屬作用 ........................................................ 32
1.12.2 噁唑啉扮演的角色 ................................................................ 33
第二章 開發新型啉類手性噁唑啉配體 ................................................. 35
2.1 研究動機 ........................................................................................ 35
2.2 配體設計 ........................................................................................ 36
2.3 與噁唑啉搭配的結構 .................................................................... 38
第三章 結果與討論 ................................................................................. 42
3.1配體的合成 ..................................................................................... 42
3.2 噁唑啉的合成 ................................................................................ 43
3.3 雜環化合物的碳氮鍵偶合反應 .................................................... 44
3.3.1 縮減銅催化碳氮鍵偶合反應步驟 .......................................... 52
3.4 銅金屬催化不對稱亨利反應條件 ................................................ 57
3.4.1亨利反應溶劑的選擇 ............................................................... 57
3.4.2中性條件催化不對稱亨利反應 ............................................... 58
3.4.3 二價銅的來源 .......................................................................... 60
3.4.4噁唑啉的手性官能基比較 ....................................................... 65
3.4.5總結 ........................................................................................... 69
3.4.6不同路易士酸造成相異位向選擇性 ....................................... 70
第四章. 結論............................................................................................ 72
第五章. 實驗部分 ................................................................................... 74
5.1儀器及藥品資料 ............................................................................. 74
A. 儀器部分 ..................................................................................... 74
B. 試藥部分 ..................................................................................... 76
溶劑部分 .................................................................................... 77
5.2 製備方法 ........................................................................................ 78
5.2.1 化合物59製備 ........................................................................ 78
5.2.2 化合物60製備 ........................................................................ 79
5.2.3 新式吡類手性噁唑啉配體47-54之合成 ............................... 80
5.2.4 新型吡類手性噁唑啉配體與銅催化不對稱亨利反應 .......... 82
第六章. 參考文獻 ................................................................................... 91
參考文獻 References
1. Sharpless, K. B.; Martin, V. S.; Woodward, S. S.; Katsuki, T.; Yamada, Y.; Ikeda, M. J. Am. Chem. Soc. 1981, 103, 6237.
2. Sabín, J. G.; Gotor, V.; Rebolledo, F. Chem. Eur. J. 2004, 10, 5788.
3. Ooi, T.; Doda, K.; Maruoka, K. J. Am. Chem. Soc. 2003, 125, 2054.
4. Rueping, M.; Udra, U. J. Am. Chem. Soc. 2011, 133, 3732.
5. He, Y. H.; Hu, W.; Guan, Z. J. Org. Chem. 2012, 77, 200.
6. Henry, M. L. Compt. Rend. 1895, 120, 1265.
7. Risgaard, T.; Gothelf, K. V.; Jørgensen, K. A. Org. Biomol. Chem. 2003, 1, 153.
8. Evans, D. A.; Seidel, D.; Rueping, M.; Lam, H. W.; Shaw, J. T.; Downey, C. W. J. Am.Chem. Soc. 2003, 125, 12692.
9. (a) Rottländer, M.; Boymond, L.; Cahiez, G.; Knochel, P. J. Org. Chem. 1999, 64, 1356. (b) Ballini, R.; Petrini, M. Tetrahedron, 2004, 60, 1017. (c) Matt, C.; Wagner, A.; Mioskowski, C. J. Org. Chem. 1997, 62, 234. (d) Stephen, C. B. Tetrahedron 2000, 56, 2561.
10. Sasai, H.; Suzuki, T.; Arai, S.; Arait, T.; Shibasaki, M. J. Am. Chem. Soc. 1992, 114, 4418.
11. Nicolaou, K. C.; Huang, X.; Snyder, S. A.; Rao, P. B.; Bella, M.; Reddy, M. V. Angew. Chem. Int. Ed. 2002, No.5, 41.
12. Zulauf, A.; Mellah, M.; Schulz, E. J. Org. Chem. 2009, 74, 2242.
13. Park, J.; Lang, K.; Abboud, K. A.; Hong, S. J. Am. Chem. Soc. 2008, 130, 16484.
14. Choudary, B. M.; Ranganath, K. V. S.; Pal, U.; Kantam, M. L.; Sreedhar, B. J. Am. Chem. Soc. 2005, 127, 13167.
15. Christensen, C.; Juhl, K.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 2002, 67, 4875.
16. Qi, M. H.; Wang, F. J.; Shi, M. Tetrahedron: Asymmetry 2010, 21, 247.
17. White, J. D.; Shaw, S. Org. lett. 2012, vol.14, No.24, 6270.
18. Liu, H.; Yang, W.; Du, D.M.; Org. Biomol. Chem. 2010, 8, 2956.
19. Pedro, J. R.; Olmos V. H.; Ferna´ndez, I.; Climent, E.; Blay, G. Tetrahedron: Asymmetry 2006, 17, 2046.
20. Arai T.; Watanabe M.; Yanagisawa A. Org. Lett. 2007, Vol. 9, NO.18, 3595.
21. Noole, A.; Lippur, K.; Metsala, A.; Lopp, M.; Kanger, T. J. Org. Chem, 2010, 75, 1313.
22. Pedro J. R.; Olmos V. H.; Domingo, L. R.; Blay G. Chem. Eur. J. 2008, 14, 4725.
23. Du, D. M.; Xu, J.; Lu, S. F.; Fang, T. J. Org. Chem. 2005, 70, 3712.
24. Jin, W.; Li, X. C.; Huang, Y. B.; Wu, F.; Wan, B. Chem. Eur. J. 2010, 16, 8259.
25. Chem. D.; Matt, P. V.; Pfaltz, A. Angew. Chem. Int. Ed. 1993, 32, 566.
26. Voituriez, A.; Schulz, E. Tetrahedron: Asymmetry 2003, 14, 339.
27. Evans, D. A.; Miller, S. J.; Lectka, T.; Matt, P. V. J. Am. Chem. Soc. 1999, 121, 7559.
28. Fu, G. C.; Cordier, C. J.; Binder, J. T. J. Am. Chem. Soc. 2012, 134, 17003.
29. Brunner, H.; Berghofer, J. J. Organomet. Chem. 1995, 161, 501.
30. Evans, D. A.; MacMillan, D. W. C.; Campos, K. R. J. Am.Chem. Soc. 1997, 119, 10859.
31. Brunner, H.; Störiko, R.; Rominger, F. Eur. J. Inorg. Chem. 1998, 771.
32. Glorius, F.; Hahn, B. T.; Tewes, F.; Frohlich, R. Angew. Chem. Int. Ed. 2010, 49, 1143.
33. Crosignani, S.; Young, A. C.; Linclau, B. Tetrahedron Lett. 2004, 45, 9611.
34. Chaudhari, R. V.; Patil, N. M.; Kelkar A. A. Tetrahedron Lett. 2002, 43, 7143.
35. Chen, Y. J.; Chen, H. H. Org. lett. 2006, 8, 5609.
36. Kreis, M.; Brase, S. Adv. Synth. Catal. 2005, 347, 313.
37. Xu, Z. L.; Li, H. X.; Ren, Z. G.; Du, W. Y.; Xu, W. C.; Lang, J. P. Tetrahedron 2011, 67, 5282.
38. Sauthier, M.; Leca, F.; Fernando, R.; Fernando, L.; Toupet, L.; Katia B. G.; Reau, R. New J. Chem. 2002, 26, 630.
39. (a) Bicak, N.; Sirkecioglu, O.; Bicak, N. Tetrahedron Lett. 2010, 51, 5313. (b) Crosignani, S.; Swinnen, D. J. Comb. Chem. 2005, 7, 688. (c) Li, Z.; Xu, Q. Tetrahedron Lett. 2009, 50, 6838.
40. Zhou, Y.; Gong, Y. Eur. J. Org. Chem. 2011, 6092-6099
41. Herradon, B.; Mann, E.; Francisco, S. S. Adv. Synth. Catal. 2001, 343, 360
42. Boppisetti, J. K.; Birman, V. B. Org. Lett. 2009, 11, 1221
43. Huang, Y.; Ni, L.; Gan, H.; He, Y.; Xu, J. Y.; Wu, X. M.; Yao, H. Q. Tetrahedron 2011, 67, 2066
電子全文 Fulltext
本電子全文僅授權使用者為學術研究之目的,進行個人非營利性質之檢索、閱讀、列印。請遵守中華民國著作權法之相關規定,切勿任意重製、散佈、改作、轉貼、播送,以免觸法。
論文使用權限 Thesis access permission:自定論文開放時間 user define
開放時間 Available:
校內 Campus: 已公開 available
校外 Off-campus: 已公開 available


紙本論文 Printed copies
紙本論文的公開資訊在102學年度以後相對較為完整。如果需要查詢101學年度以前的紙本論文公開資訊,請聯繫圖資處紙本論文服務櫃台。如有不便之處敬請見諒。
開放時間 available 已公開 available

QR Code